Clinical-stage precision oncology company developing therapies targeting the RAS/MAPK pathway to erase cancer.
Get notified the moment Erasca files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.